Top Markets
#1 EXOD EXOD +56.80%
#2 CoW Protocol CoW Protocol +55.52%
#3 Glidr Glidr +38.71%
#4 Cysic Cysic +28.33%
#5 Walrus Walrus +25.77%
#6 Humanity Humanity +25.08%
#7 Enso Enso +18.12%
#8 Velvet Velvet +16.00%
#9 Tutorial Tutorial +15.35%
#10 OVERTAKE OVERTAKE +15.31%
Coin of the day
EXOD EXOD
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Quantum Genomics S.A. Quantum Genomics S.A.

Quantum Genomics S.A.

ALQGC
Rangering i aksjer #37063
Quantum Genomics S.A., a biopharmaceutical firm established in Paris, France,... Quantum Genomics S.A., a biopharmaceutical firm established in Paris, France, in 2005, focuses on creating treatments for cardiovascular ailments. Its therapeutic approach utilizes the brain aminopeptidase A inhibition (BAPAI) platform, primarily addressing high blood pressure (hypertension) and heart failure. The company's key asset, firibastat, is currently undergoing a crucial Phase III study as a standalone therapy for hypertension and is also in clinical trials for heart failure. Additionally, Quantum Genomics is progressing QGC011 for hypertension in combination therapy, and further developing QGC006 and QGC606 to target both hypertension and heart failure.
Aksjekurs
$0.07600875
Sist synkronisert: 2024-11-20
Markedsverdi
$2.06M
Endring (1 dag)
-0.51%
Endring (1 år)
0.00%
Land
FR
Handel Quantum Genomics S.A. (ALQGC)

Kategori

Healthcare
Antall utestående aksjer for Quantum Genomics S.A. (ALQGC)
Antall utestående aksjer per December 2024: 69.71M
Ifølge Quantum Genomics S.A. sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 69.71M. Ved slutten av December 2023 hadde selskapet 34.86M utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Quantum Genomics S.A. (ALQGC) fra 2009 til 2026
Utestående aksjer ved utgangen av hvert år
År Utestående aksjer Endre
2026 (TTM) 69.71M 0.01%
2024 69.71M 99.98%
2023 34.86M 0.96%
2022 34.53M 28.05%
2021 26.96M 32.10%
2020 20.41M 13.53%
2019 17.98M 14.39%
2018 15.72M 43.77%
2017 10.93M 30.86%
2016 8.35M 20.85%
2015 6.91M 43.72%
2014 4.81M 16.49%
2013 4.13M 84.23%
2012 2.24M 877.02%
2011 229.39K 0.00%
2010 229.39K 0.00%
2009 229.39K 0.00%
Utestående aksjer for lignende selskaper eller konkurrenter
Selskap Utestående aksjer Forskjell Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 264.21%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -10.80%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -100.00%
BE